If Vicore were a US-listed company, its valuation would be multiple times higher. The best proof is Pliant, a company in a similar state of development with much worse drug results. Vicore hired a new Boston-based CEO whose claim is to connect Vicore to a US investor base. The new Vicore CEO is now starting … Continue reading Vicore – New US-Based CEO Starts Onboarding US Investors